Introduction
The v-Abl non-receptor tyrosine kinase, encoded in the Abelson Murine Leukemia Virus (A-MuLV), is an acutely transforming oncoprotein that gives rise to early B lymphoma in vivo and transforms early B cells, other hematopoietic cells and sublines of 3T3 ®bro-blasts in vitro. v-Abl provides a good model for studying the complex processes of malignant transformation in both ®broblasts and preB cells. In the context of 3T3 cell transformation, signals from v-Abl can replace the growth signals these cells normally require from serum mitogens and from attachment to the extracellular matrix. In preB cells v-Abl activity is only required for progression from G0/G1 into S phase (Chen and Rosenberg, 1992) and it is likely to play a similar role in other cell lineages. Indeed, previous work from this lab has demonstrated that one consequence of v-Abl expression in 3T3 cells is induction of c-myc transcription, which is dependent on an E2F site in the c-myc promoter. This provided the ®rst evidence that v-Abl aects proteins that regulate G1 to S phase progression (Wong et al., 1995) . Similar results have been obtained for BCR-ABL, a human oncoprotein related to v-Abl (Birchenall-Roberts et al., 1997) . Further investigation of cmyc induction by v-Abl has shown that it requires Ras, Raf, and cyclin-dependent kinase activity, leading to changes in the regulatory complexes that bind to the cmyc E2F site (Zou et al., 1997) .
In order to achieve a more complete understanding of the signaling pathways by which v-Abl regulates molecules that control G1 to S progression, we took advantage of a 3T3 cell line transformed with a temperature sensitive form of v-Abl to investigate G1 to S cell cycle progression dependent on v-Abl. This system allows v-Abl-dependent signals, which replace adhesion or serum mitogens, to be studied independently. Regulation of cell cycle progression through G1 is known to converge at the activity of G1 cyclin dependent kinases. These kinases are regulated in many ways including altering the levels of cyclin mRNAs, especially D cyclins, the phosphorylation state of the cyclin dependent kinases (CDKs) and the presence or absence of CDK inhibitors (Sherr and Roberts, 1995; DelSal et al., 1996) . One critical substrate of G1 cyclin dependent kinases is the Rb family of proteins; the phosphorylation state of Rb family proteins then determines the ability of E2F proteins to regulate transcription of E2F-dependent genes.
Based on the previous identi®cation of the E2F site in the c-myc promoter as a v-Abl response element, we asked if other E2F-regulated genes are also induced by v-Abl. The results show that v-Abl induces all the E2F-dependent genes we analysed and that vAbl-dependent induction of the DHFR promoter is, like that of the c-myc promoter, dependent on E2F sites. We also investigated mechanisms by which v-Abl activates CDKs under conditions where it replaces either mitogenic or adhesion signals. Our data show that v-Abl induces cyclin D1 and D2 mRNA in serum-depleted cells. We also show that levels of the CDK inhibitor p27 decrease signi®cantly when v-Abl replaces either a mitogenic or an adhesion signal. These results underscore the importance of E2F-dependent signaling by v-Abl and identify two previously unknown mechanisms by which v-Abl regulates progression of cells through G0/G1 into S phase.
Results
Signals from v-Abl release serum starved or density arrested 3T3 cells from quiescence
We utilized the NIH3T3 ®broblast-derived D5 cell line to study how v-Abl overcomes growth arrest at G1/G0. The D5 cell line is transformed with a mutant form of v-Abl in which the tyrosine kinase activity is temperature sensitive (Renshaw et al., 1992) . At the temperature which non-permissive for v-Abl kinase activity (398C), these cells grow as adherent 3T3 cells, displaying serum and anchorage dependence. At the permissive temperature (328C), the v-Abl kinase becomes active and permits the cells to grow in a serum-and anchorage-independent manner. Thus, we can study the cells under conditions where v-Abl replaces mitogenic signals, or replaces signals normally provided through anchorage to substratum.
To compare mitogenic signals from v-Abl and serum, D5 cells at the non-permissive temperature were growth arrested by serum deprivation and then either transferred to medium containing serum or switched to 328C. Similarly, to study how v-Abl replaces signals from the extracellular matrix, D5 cells were grown at the non-permissive temperature until they became density arrested. These cultures were then shifted to 328C to activate v-Abl. The temperature sensitivity of v-Abl tyrosine kinase in D5 cells was con®rmed using a standard autophosphorylation assay (data not shown). Figure 1 shows the kinetics of entry into S, measured by bromodeoxyuridine (BrdU) uptake, after release of D5 cells from serum deprivation (left and center panels). Following growth arrest in serum depleted medium at the non-permissive temperature, half the cells were switched to the permissive temperature and the other half was transferred to medium containing 10% serum at the non-permissive temperature. Although the cells in the two cultures take dierent lengths of time to progress through cycle, presumably due to the dierent temperatures, both serum mitogens and v-Abl induce more than 50% of the cells to enter S phase. Figure 1 , right panel, demonstrates v-Abl dependent growth of D5 cells after density arrest. D5 cells were plated at high concentration (3.3610 5 cells/ml) in fresh medium. After 48 h, the maximal number of cells had become quiescent (about 18% showed BrdU incorporation, essentially the same level achieved after serum deprivation). The cultures were then switched to 328C; they started to re-enter the cell cycle within 8 ± 10 h. These data con®rm the ability of v-Abl to replace serum mitogens and adhesion signals in D5 cells (Renshaw et al., 1992) and provide the basis for studies using these growth conditions to explore signaling by v-Abl.
v-Abl induces steady state mRNA of E2F-regulated genes including c-Myc, DHFR, ribonucleotide reductase, cyclin E and cyclin A In previous work, we had demonstrated that v-Abl activates c-myc transcription via an E2F site in the cmyc promoter and also showed that isolated E2F sites confer v-Abl responsiveness on a heterologous promoter (Wong et al., 1995; Zou et al., 1997) . These ®ndings suggested that v-Abl might induce other E2F-regulated genes under physiological conditions. Binding sites for E2F proteins (a family of ®ve genes, designated E2F1-5, together with their binding partners DP1 or DP2) have been identi®ed in the promoters of many genes that are cell cycle regulated and responsive to mitogenic signals. Included are genes whose products are essential for growth and cell cycle control (cyclin E, cyclin A, c-myc, p107 and E2F1) and DNA replication (DNA polymerase a, ribonucleotide reductase, thymidine kinase, dihydrofolate reductase).
To test the ability of v-Abl-dependent signaling to induce E2F-regulated genes other than c-myc, we measured steady state mRNA levels of representative E2F-regulated genes following v-Abl dependent release of D5 cells from either serum deprivation (Figure 2a and b) or density arrest (Figure 2c ). Figure 2a shows representative data from riboprobe protection assays for c-myc and cyclin E mRNA. Figure 2b summarizes the results of all the riboprobe analyses for steady-state mRNA performed on serum-deprived cells following shift to 328C (v-Abl-dependent growth) or after addition of serum at the nonpermissive temperature (serum-dependent growth). Time points were chosen to represent comparable stages of cell cycle, determined by percent of cells in S phase (see Figure 1 ). The time course shows points throughout the G0/G1 to S transition, from quiescent cells, with less than 19% of BrdU incorporation, to mid S phase when DNA synthesis was maximum. Riboprobe data were quantitated using phosphorimager analysis, normalized to inlane GAPDH mRNA controls, and are representative of at least three experiments.
v-Abl induced steady-state mRNA for all of the E2F-regulated genes studied following serum depriva- Figure 1 v-Abl can replace the signals normally received from serum or from contact with substratum. The kinetics of DNA synthesis was measured by determining the percentage of cells incorporating BrdU. In left and center panels, D5 cells were grown at 398 and deprived of serum for 36 h. Half of the cultures were switched to temperatures permissive for v-Abl function (left panel,`vAbl'), while the other half were kept at 398 after the addition of complete media (center panel,`serum'). In right panel, density arrested cultures of D5 cells in complete media were transferred to 328 (`v-Abl') v-Abl uses multiple mechanisms to advance G1/S M Coutts et al tion (Figure 2b ). When serum-and v-Abl-dependent growth were compared, ribonucleotide reductase (RR) and cyclin A mRNA showed similar induction patterns in response to either v-Abl or serum mitogens. RR showed 26 induction; cyclin A showed a maximal increase of 26 for serum and 36 for v-Abl at mid S phase, but earlier points showed an equal induction. vAbl induced c-myc slightly more than serum, 66 compared to 56. Alternatively, v-Abl induced two genes less strongly than serum. For cyclin E and DHFR, the increases were 2.56 versus 1.76 and 36 versus 26 for serum and v-Abl respectively. As a control for a gene whose expression is not cell cycle-or E2F-regulated, CDK4 mRNA levels were also determined and found not to change. Steady-state mRNAs for E2F-regulated genes were also induced when density arrested cells were shifted to the permissive temperature to allow v-Abl-dependent growth (Figure 2c ). c-Myc mRNA showed the greatest increase, 4.56 by mid S phase. Cyclin E showed a 2.56 increase, DHFR and RR were induced 2.66 and 2.5-to 36, respectively.
These data show that v-Abl induces all the E2F-regulated genes in our study, suggesting the possibility that most or all E2F-regulated genes are induced by vAbl. Furthermore, v-Abl signaling in the context of either serum-deprivation or density arrest is sucient to cause induction of E2F-regulated genes. A comparison of the patterns of induction by v-Abl and serum mitogens shows only modest dierences in induction patterns, suggesting that v-Abl and serum mitogens have similar outcomes and may utilize similar signaling pathways for these E2F-dependent genes.
Induction of DHFR expression by v-Abl depends on E2F sites in the DHFR promoter
Steady-state mRNA levels re¯ect mRNA stability as well as transcription initiation. However, it seemed likely that v-Abl-dependent conversion of E2F proteins from transcriptional repressors to transcriptional activators, which has been shown to occur in D5 cells in the context of the c-myc gene (Zou et al., 1997) , was likely to be responsible for the induction of mRNA corresponding to the other E2F-regulated genes observed in Figure 2 . To test this possibility, we used cotransfection experiments to determine if v-Abl could induce transcription of the DHFR promoter and if that induction was dependent on E2F sites.
A v-Abl expression plasmid was transfected into 4A2 cells, along with a luciferase reporter dependent on a wild type DHFR promoter (Slansky et al., Steady state mRNA levels of E2F dependent genes were determined by riboprobe analysis. (a) shows mRNA levels of cmyc, cyclin E, and GAPDH controls in D5 cells that were serum deprived for 36 h, and then treated with either media complete with 10% serum (`S') or through activation of v-Abl (`A') by temperature shift. Cells were harvested in the quiescent state, or at times corresponding to early G, mid G, or S phase (as measured by BrdU incorporation). (b and c) Bands protected in the riboprobe assay were quantitated by phosphoimager analysis and normalized to in-lane GAPDH controls. The y-axis is in arbitrary phosphorimager units; the x-axis shows the percent of cells in S phase. (b) shows message levels from various E2F dependent genes after serum deprivation, comparing levels after vAbl activation (dark symbols) to the levels induced by the addition of serum (open squares). (c) shows mRNA levels of E2F dependent genes in response to v-Abl, after density arrest v-Abl uses multiple mechanisms to advance G1/S M Coutts et al 1993). The DHFR promoter sequences extended from 7270 to +20 (relative to the transcription start site), and contained two overlapping E2F sites located at 711 to +11 bp. These transfections were compared to ones in which luciferase expression depended on a DHFR promoter in which both E2F sites were mutated (Figure 3, right panel) . v-Abl induced the wild type DHFR promoter approximately tenfold, while induction was only 2.6-fold in transfections utilizing the promoter with mutated E2F sites ( Figure  3 , left panel). Thus, v-Abl-dependent induction of the reporter was strongly dependent on the presence of E2F binding sites and E2F binding sites are important v-Abl response elements in the DHFR promoter.
Signals from v-Abl result in CDK activation
The precisely timed expression of E2F-dependent genes re¯ects the cumulative eects of many regulators. The retinoblastoma family proteins (pRb, p107 and p130) are one important set of E2F regulators. Rb family proteins physically associate with E2F-DP heterodimers and convert them to transcriptional repressors (reviewed in Dyson, 1998) . CDK-dependent phosphorylation of Rb family proteins releases them from association with E2F-DP heterodimers, relieving transcriptional repression and, in some cases, causing transcriptional activation. This phosphorylation takes place by a sequential and cooperative mechanism, initiated by CDK4/6-cyclin D complexes, and then completed by CDK2-cyclin E complexes . We have previously shown that v-Abl causes activation of both CDK4/6-cyclin D and CDK2-cyclin E in serum starved cells. Here we tested the activities of CDK4 and CDK2 in cells where v-Abl replaced anchorage signals.
Kinase activities were assayed in vitro, after immunoprecipitation of CDK2 or CDK4 complexes (Figure 4 ). Kinase activities were compared in lysates from density arrested D5 cells and cells that had been shifted to temperature permissive for v-Abl activity for 15 h (sucient time for 50% of the cells to become active in DNA synthesis, as determined through kinetic analysis of BrdU uptake, Figure 1 ). CDK complexes were precipitated using polyclonal antibodies speci®c to the carboxy terminus of CDK2 or CDK4. A histone substrate was added to the CDK2 immunoprecipitate; a GST-Rb substrate was used to assay the kinase activity associated with the CDK4 immunoprecipitate. Products of the kinase reaction were resolved on SDS polyacrylamide gels. The transfer of g-32 P to the substrates was quantitated by phosphorimager analysis. Figure 4 shows data representative of several experiments. The left panel shows CDK2 activity, and a control assay performed without the addition of substrate. Density-arrested cells showed a low level of CDK2 activity, while cells shifted to temperature permissive for v-Abl activity showed a ®vefold increase of g-phosphate transfer to substrate. The right panel of Figure 4 shows a parallel assay for CDK4 activity. The same temperature shifted cell extracts showed a 2.5-fold increase in immunoprecipitated CDK4 activity. Western blot assays were used to verify that the immunoprecipitations were completely ecient, and that CDK protein levels had not changed after temperature shift (lower panels). Thus, when v-Abl replaces either mitogenic or adhesion signals, CDK activity is increased. Figure 4 CDK2 and CDK4 activities increase in response to vAbl. D5 cells were density arrested; then part of the cultures were shifted to 328 for 15 h. Cell lysates were immunoprecipitated with an antibody to CDK2 or CDK4; complexes were washed and then assayed for kinase activity after the addition of appropriate substrate. Histone was used as a substrate for CDK2; and Rb-GST fusion protein was used as a substrate in CDK4 assays. As a control, immunoprecipitated complexes were also incubated without substrate (`No S') v-Abl uses multiple mechanisms to advance G1/S M Coutts et al v-Abl induces steady-state cyclin D1 and D2 mRNA in serum-depleted 3T3 cells D cyclins are required early in G1/S progression to activate CDK4/6; transcription of D cyclin genes is induced by mitogens (Sherr, 1996) . We used D5 cells to determine how v-Abl aects steady-state levels of D cyclin mRNA. The steady state mRNA levels of cyclin D1, D2 and D3 are reported in Figure 5 . The top panel compares levels after D5 cells were released from serum deprivation, either by transfer to serum-rich media or by temperature shift to 328C. Both of these treatments strongly induce cyclin D2 (about ninefold) while cyclin D1 is induced 2.5-fold by serum and twofold by v-Abl. A corresponding 5.5 ± 6-fold increase in cyclin D1 and D2 protein was veri®ed by Western blot analysis (data not shown). Levels of cyclin D3 mRNA did not change signi®cantly in response to either v-Abl or serum. Thus, v-Abl causes induction of cyclin D1 and D2. However, density arrested cells show little change in cyclin D mRNA levels after transfer to temperature permissive for v-Abl function and re-entry into cycle. The cyclin D1 and D2 mRNA levels in density arrested cells ( Figure 5 lower panel) are approximately the same as those found in cells responding to treatment with serum (upper panel). This is consistent with the presence of serum mitogens in the media of density arrested cells. Thus, in D5 cells that are growth arrested due to lack of adhesion signals, D cyclin mRNA levels are already high and are not increased further by v-Abl activation.
v-Abl causes a decrease in p27 in both serum-deprived and density arrested 3T3 cells CDK activity can be blocked by speci®c CDK inhibitors, either members of the Cip/Kip family, and/or the Ink family (Morgan, 1995; Harper, 1997) . p27 has been shown to be elevated in ®broblasts arrested at G1 by either serum deprivation or lack of adhesion signals. Its role as a checkpoint regulator in cells lacking adhesion signals is particularly welldocumented (Assoian and Zhu, 1997). Thus we investigated levels of p27 in D5 cells where v-Abl replaced either mitogenic or adhesion signals.
p27 protein was measured in serum-deprived and density-arrested D5 cells. Western blot analyses showed that p27 was high in both types of growth arrested cells, but dropped signi®cantly after transferring the cells to serum-rich media, or after activation of v-Abl. Figure 6a (left panel) shows that there is a comparable decrease in p27 protein after serum addition or v-Abl activation. Figure 6a (right panel) shows a similar decrease in p27 levels after release from contact inhibition. The changes in p27 levels were not due to an overall decrease in protein concentration or variations in sample handling since b actin levels were unchanged when the Western blots were reprobed with an antibody to b actin (lower panel). All three treatments (serum addition, or v-Abl activation after serum deprivation or density arrest) show a decrease in p27 that corresponds to changes in CDK activity and progression through G0/G1 into S.
v-Abl causes induction of c-Myc (Cleveland et al., 1989) and ectopically expressed c-Myc has been reported to cause a decrease in p27 in RAT1 cells (Vlach et al., 1996) . Therefore, we wished to determine if the v-Abl-dependent decrease in p27 we observed was secondary to v-Abl-dependent increase in c-Myc by determining if new RNA or protein synthesis was required for the eect. A time course of v-Abl activation was performed in density arrested cells, with or without the addition of inhibitors cycloheximide or actinomycin D (Figure 6b ). When p27 levels were Figure 6 Levels of p27 decrease after activation of v-Abl. (a and b) Levels of p27 and actin were evaluated by Western blot. In the left panel of a, whole cell extracts were prepared from cells growth arrested through 36 h of serum deprivation. Cells were harvested after growth was initiated, by addition of complete media (`serum') or after shifting the cultures to 328, a temperature permissive for v-Abl activity (`v-Abl'). In the left panel of a, cells were made quiescent by density arrest and then shifted to 328. (b) Illustrates that the v-Abl dependent reduction of p27 does not require new RNA or protein synthesis. Density arrested D5 cells were shifted to 328, with or without the addition of cycloheximide (`CHX') or actinomycin D (`Act D'). Samples were taken for analysis 7.5 and 15 h after temperature shift (when 21 and 40% of the cells resp. were in S phase). (c) Shows the association of p27 with CDK2 and CDK4 before and after release from growth arrest. Whole cell lysates were prepared from D5 cells made quiescent through serum deprivation or density arrest, and from growth arrested cultures that had been transferred to 328 for 15 h (`v-Abl'). The lysates were immunoprecipitated with antibodies to CDK2 (upper panel) or CDK4 (lower panel). Parallel samples of these lysates were also immunoprecipitated using anti-p27 antibodies. Both immunoprecipitates (`P') and their supernatants (`S') were electrophoresed on SDS ± PAGE gels, transferred to nitrocellulose and immunoblotted with a monoclonal antibody to p27. Control immunoblots showed that CDK2 and CDK4 were quantitatively immunoprecipitated in these experiments (not shown) We also determined if v-Abl activation changed the amount of p27 associated with cyclin dependent kinases in D5 cells. Immunoprecipitates were prepared from D5 cells after serum deprivation or density arrest and after the arrested cells had been shifted to 328C for 15 h. Immunoprecipitations were performed with antibodies against CDK2 or CDK4; the immunoprecipitates and their supernatants (`P' or`S' in Figure 6c ) were evaluated for p27 content by immunoblotting. As a control, the lysates were precipitated and blotted with p27, to show p27 antibody speci®city and anity, and to account for the total amount of protein in the analysis. Typically, 15 ± 25% of the total p27 was associated with CDK2 in G1 arrested cells. After v-Abl was activated, the total amount of p27 was reduced approximately ®vefold and none was detected in association with CDK2. This was true for experiments where cells progressed into S phase following serum deprivation or density arrest (Figure 7 ). It was also true for serum-deprived cells following addition of serum (data not shown). Most of the p27 protein in growth arrested cells was associated with CDK4 (65 ± 75%). Although there was still p27 associated with CDK4 following activation of v-Abl, the absolute amount of p27 associated with CDK4 decreased 3 ± 5-fold. These results are consistent with our ®nding that activities of both CDK4 and CDK2 increase following v-Abl activation ( Figure 4 ) and with previous data showing that p27 association inhibits CDK activity. Thus our data are consistent with the idea that p27 is important for growth arrest of serum or adhesion deprived D5 cells and that v-Abl causes a decrease in p27 which is necessary to enter S phase.
Discussion

Induction of E2F-dependent genes by v-Abl
We have previously show that v-Abl activates c-myc transcription through the E2F site in the c-myc promoter and that multimerized E2F sites are sucient to confer v-Abl responsiveness on a minimal promoter (Wong et al., 1995) . The results presented here extend these studies to show that mRNAs encoding additional E2F-dependent genes are also induced in response to vAbl. These include DHFR, ribonucleotide reductase, cyclin E and cyclin A. We also demonstrate directly that v-Abl induction was dependent on E2F sites in the context of a second gene, DHFR. Thus, c-myc is not a unique E2F-dependent target of v-Abl in vivo. We suggest that most, possibly all, E2F-dependent genes are induced in response to v-Abl and that this induction is critical for the transforming activity of vAbl.
Following v-Abl activation, mRNA levels of the E2F-dependent genes studied increased 2 ± 6-fold. Induction of the E2F target genes occurred in both serum-deprived and density arrested cells in response to v-Abl. Dierences in the magnitude and/or kinetics of induction for some of these genes when v-Abl was compared to serum mitogens were relatively minor ( Figure 2b ). We interpret these data to show that v-Abl and serum mitogens have similar eects on E2F-dependent gene transcription in the presence of adhesion signals. However, v-Abl can still induce these genes in the absence of adhesion signals whereas serum mitogens cannot.
v-Abl induces cyclin D1 and D2 mRNA
Normal mitogens induce transcription of D cyclin genes; however, D cyclins have short metabolic halflives and their levels drop if mitogenic signals are withdrawn (Sherr, 1996) . Sucient levels of one or more of the D cyclins must be present for progression through G1 into S phase. Our results show that when mitogens are absent, v-Abl can induce cyclin D1 and D2 mRNA in 3T3 D5 cells ( Figure 5, upper panel) . However, our data also show that the presence of cyclin D1 and D2 mRNA is not sucient for density arrested D5 cells to enter cycle. These cells, which are not depleted of serum mitogens, have levels of cyclin D1 and D2 mRNA comparable to log phase cycling cells and cyclin D mRNA levels are not further increased upon v-Abl activation ( Figure 5 , lower panel).
The mechanism by which v-Abl induces cyclin D1 and D2 mRNA is not known but is likely to be distinct from the signaling pathway by which v-Abl induces cmyc and other E2F-dependent mRNAs (Wong et al., 1995) . Although the promoters of the cyclin D1 and D2 genes have not been fully characterized, no functional E2F sites have been found in them (Brooks et al., 1996) . Other groups have suggested that the cyclin D1 promoter may be regulated through a MAPK-dependent mechanism (Lavoie et al., 1996) . vAbl activates Ras, Raf and MAPK (Weissinger et al., 1997) and it will be interesting to determine if MAPK is involved in v-Abl-dependent induction of cyclin D1 or cyclin D2 mRNA. Another possibility is regulation through STAT pathways since v-Abl activates STATs (Danial et al., 1995 (Danial et al., ), 1998 and STAT5 has recently been shown to activate cyclin D1 transcription (Matsumura et al., 1999) .
v-Abl causes a reduction in CDK inhibitor p27
Inhibitors of cyclin dependent kinases play an important role in arresting cell cycle when DNA is damaged or when appropriate nutrients or signals are absent. p27 levels are high in many types of quiescent cells and p27 down regulation correlates with emergence from G0 after serum treatment Nourse et al., 1994) . Similarly, cells that are quiescent due to lack of attachment to substratum have high p27 levels (Coats et al., 1996; Fang et al., 1996; Polyak et al., 1994; Zhu et al., 1996) . Thus, the role of p27 as a repressor of cell proliferation is well established and p27 levels can be regulated by both mitogenic and adhesion signals.
The p27 inhibitor may play a particularly important role in 3T3-D5 cells, since these cells have a mutation in the INK4a gene (Quelle et al., 1995) and p21 levels do not change upon v-Abl activation (X Zou, unpublished observation). Our data show that without v-Abl, both mitogenic and adhesion signals are v-Abl uses multiple mechanisms to advance G1/S M Coutts et al required for D5 cells to decrease p27 ± neither signal alone is sucient. However, our data also show that vAbl is sucient to provide both signals and v-Abl causes a decrease in p27 in either density arrested or serum-depleted cells (Figure 6a ). v-Abl's ability to overcome G1 arrest correlates with decreases in p27, suggesting that p27 is an important target of v-Abl signaling.
p27 associates with CDK2 and CDK4, but CDK2 and CDK4 are not equivalent targets of p27. In some situations cyclin D/CDK4 may serve as`reservoir' for p27 since it has a greater ability to bind p27 and is less susceptible to inhibition (Blain et al., 1997; Reynisdottir et al., 1995) . This is consistent with our observation that the greater part of p27 in G1 arrested D5 cells is associated with CDK4 rather than CDK2. However, the amount of p27 in density arrested D5 cells is likely to inhibit CDK4/6 activity since v-Abl activation and entry into cycle correlate with the decrease in p27 and an increase in CDK4/6 activity. In serum depleted D5 cells, cyclin D1 and D2 mRNA levels are low and lack of D cyclins, as well as the presence of elevated p27, is probably important for G1 arrest.
Previous reports show that enforced expression of cMyc in RAT1 cells causes release of p27 from CDK/ cyclin E complexes and degradation (Muller et al., 1997) . However, our data show that the v-Abldependent decrease in p27 we observe does not depend on synthesis of c-Myc since it is not blocked by cycloheximide treatment (Figure 6b) . The mechanism by which v-Abl causes a decrease in p27 is currently under investigation in our laboratory. We have found that the v-Abl-dependent eect does not involve p27 mRNA levels or the rate of p27 synthesis but depends on proteasome-dependent degradation of p27 (X Zou, M Coutts and K Calame, unpublished results). In other cell types, p27 degradation has been shown to be dependent on activated Ras (Aktas et al., 1997; Takuwa and Takuwa, 1997) , MAPK (Alessandrini et al., 1997) and/or CDK2 activity (Nguyen et al., 1999) . It will be interesting to determine the signal pathway from v-Abl to p27 degradation.
These studies have revealed several new aspects of vAbl activity: induction of multiple E2F-dependent mRNAs, induction of cyclin D1 and D2 mRNA and decrease in p27 levels. However, all of these events occur in response to normal serum mitogens and/or substratum signals as well as in response to v-Abl. While it is formally possible that the signals initiated by v-Abl activate novel signal transduction pathways, our results show that v-Abl activates many or all of the same signaling pathways that are activated by normal growth regulators. It appears that constitutive activation of normal pathways, rather than activation of new or unusual signaling pathways, is characteristic of cell cycle regulation in v-Abl transformed 3T3 cells.
Materials and methods
Cell culture and growth analysis
Serum starved cells were prepared by ®rst growing D5 cells (Renshaw et al., 1992) to 50% con¯uency in complete media (DMEM with 10% fetal calf serum) at 398C. The cells were rinsed with phosphate buered saline and the media was replaced with DMEM with 0.2% fetal calf serum. Cells were returned to 398C in a humidi®ed, 5% CO 2 atmosphere for 36 h. At that time, cells were viable but DNA synthesis had reached a minimum. Cell growth was initiated by replacing the low-serum media with complete media, or by shifting the cells to the temperature permissive for v-Abl kinase activity (328C). Density arrest of the D5 cells was performed by growing cells to complete con¯uency, passaging the cells 1/3 in fresh media, and returning them to a 398C incubator for 48 h. They became completely con¯uent within 22 h and reached a minimal level of DNA synthesis by 48 h. Growth was initiated by switching the cells to 328C. All cell cultures used for experiments were determined to be 495% viable, as determined by trypan blue staining (supplied by Sigma, St Louis, MO, USA). In studies where cells were treated with cycloheximide or actinomycin D, the drugs were used at concentrations of 20 mg/ml and 0.5 mg/ml, respectively (supplied by Sigma, St Louis, MO, USA). The drugs were added immediately before the cultures were transferred to temperatures permissive for v-Abl function (328C). For measurements of total protein synthesis, cells were grown in methionine free-media (Specialty Media, Inc. Lavallette, NI, USA) for 2 h, then supplemented with [ 35 S]methionine (50 mCi/ml) for 1.50 h. Incorporation of radioactive amino acid was determined by trichloro acetic acid incorporation.
DNA synthesis was measured by determining the incorporation of BrdU during a 1 h incubation (after the addition of 10 mM BrdU). The cells were ®xed, denatured, neutralized and then mixed with a FITC-conjugated antiBrdU monoclonal antibody (Pharmingen, San Diego, CA, USA) as the manufacturer recommended prior to analysis bȳ ow cytometry. Steady state mRNA levels were evaluated by RNase protection (Ausubel, 1987) after isolation of total RNA (Puissant and Houdebine, 1990 ). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels were used as an internal control in all experiments and were used to normalize gel loading and sample handling. Quantitation was performed using PhosphorImager and ImageQuant software from Molecular Dynamics (Sunnyvale, CA, USA).
Transfections
4A2 cells (a 3T3 ®broblast subclone permissive for v-Abl transformation) (Renshaw et al., 1992) were used for transfection assays. Monolayer cultures (5610 5 cells) were seeded into 10 cm plates 1 day prior to transfection, and fed fresh medium (IMDM with 10% newborn calf serum) 3 h before transfection. Cells were transfected with 5 mg v-Abl and 5 mg DHFR reporter plasmid DNA, using a calcium phosphate treatment (Chen and Okayama, 1988) . After an overnight incubation with the DNA, cells were washed and plated with fresh medium with 0.5% newborn calf serum. Cell extracts were prepared 96 h later, and luciferase levels assayed as described previously (Riggs et al., 1993) . The vAbl expression construct was described in (Renshaw et al., 1992) , the DHFR reporter in (Slansky et al., 1993) . Data is representative of six transfections, each performed in duplicate or triplicate.
Immunoprecipitations, kinase assays and Western blots
Cell lysis was performed under mild conditions, essentially as . The kinase activities of CDK2 and 4 were assayed using standard protocols (Phelps and Xiong, 1997; Shea, 1997) . Brie¯y, histone H1 (Boehringer Mannheim, Indianapolis, IN, USA) was used as a substrate for CDK2, and an Rb-GST fusion protein (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) was used as a substrate for CDK4. Kinase assays were performed with CDKs immunoprecipitated from cell lysates using polyclonal antibodies (sc-163-R for CDK2 and sc260-R for cDK4, v-Abl uses multiple mechanisms to advance G1/S M Coutts et al pulled down with protein A agarose beads, all from Santa Cruz Biotechnology, Inc). Twenty-®ve mg of cell lysate protein and 1.25 ml [g-32 P]ATP (10 mCi/ml; 4000 Ci/mmol) were used for CDK2 assays, while 100 mg protein and 6 ml gATP was used for CDK4 assays. The amount of radioactivity transferred to substrate was measured by resolving the products of the kinase reaction on SDS-polyacrylamide gels and performing quantitation with a PhosphorImager and ImageQuant software from Molecular Dynamics (Sunnyvale, CA, USA).
Western blots and coimmunoprecipitations were performed using the same antibodies as those used for the kinase assays. An anti-p27 antibody (sc-528 or sc-1641, both from Santa Cruz Biotechnology, Inc) and anti-b actin monoclonal antibody (AC-15, from Sigma, St Louis, MO, USA) were also used. Cyclin D1 and D2 protein levels were evaluated using a speci®c antibody (Santa Cruz sc-8396). The method used was described previously (Zou et al., 1997) .
Total protein concentration of cell extracts was measured using a Bio-Rad Laboratories protein assay dye reagent, as suggested by the manufacturer (Bio-Rad Laboratories, Hercules, CA, USA). Bovine serum albumin was used as a protein standard.
